Axial Spondyloarthritis
Axial Spondyloarthritis (AS) is a type of inflammatory arthritis that primarily affects the spine and the sacroiliac joints, leading to pain and stiffness in the back and hips.
Psoriatic Arthritis and Axial Spondyloarthritis: Sonelokimab Study
We are exploring how sonelokimab affects disease activity in patients with active psoriatic arthritis or axial spondyloarthritis. This study will help us understand its potential benefits and safety.
3-6 months6-10 visitsEfficacy phase (II)No PlaceboInvestigational MedicinesInjectionInternal MedicineRheumatology
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Psoriatic Arthritis
Psoriatic Arthritis (PsA) is a form of arthritis that affects some people with psoriasis, causing joint pain, stiffness, and swelling, along with skin symptoms.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Do you have a confirmed diagnosis of psoriatic arthritis (PsA) or axial spondyloarthritis (axSpA)?
- Are you currently pregnant or breastfeeding?
- Are you taking any medications that suppress your immune system, like steroids or biologics?
- Have you had any major surgery in the last 6 months?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Sonelokimab
Ga-FAPI
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Universitaetsklinikum Erlangen AöR
Medizin 3
Erlangen, Germany
Sponsor: MoonLake Immunotherapeutics AG
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.